Literature DB >> 1644249

Subclinical diabetic neuropathy: similarities between electrophysiological results of patients with type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus.

P H Hendriksen1, P L Oey, G H Wieneke, B Bravenboer, J D Banga.   

Abstract

Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetic patients share many clinical and biochemical characteristics. However, sural nerve biopsies from patients with advanced and chronic neuropathy show ultrastructural differences between these two groups. We investigated whether at a subclinical stage of the illness, when Type 1 and Type 2 diabetic patients are clinically uniform and the histopathological nerve alterations are not advanced, comparison between the two diabetes groups might show differences in nerve fibre involvement related to the different pathogeneses of the neuropathies. A total of 88 diabetic patients (52 Type 1 and 36 Type 2), with a subclinical form of polyneuropathy were selected. The clinical neurophysiological examination consisted of motor and sensory nerve conduction studies, Hoffmann (H)-reflex, single fibre electromyography and static as well as dynamic pupillometry. With regard to clinical neurophysiological abnormalities, the severity of the polyneuropathy appeared to be equal in both groups. Despite the absence of clinical symptoms the neurophysiological abnormalities were pronounced and it was impossible to differentiate Type 1 diabetic patients from Type 2 diabetic patients on a clinical neurophysiology basis when correcting for differences in age, height, and duration of illness. In the Type 1 diabetic group as well as in the Type 2 diabetic group the autonomic nerve fibres and nerves in the legs were more frequently affected than the thick myelinated nerves in the arms. These findings do not support the assumption that there is a difference in the manifestation of polyneuropathy between Type 1 and Type 2 diabetic patients.

Entities:  

Mesh:

Year:  1992        PMID: 1644249     DOI: 10.1007/bf00400264

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  29 in total

1.  Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy.

Authors:  A A Sima; V Nathaniel; V Bril; T A McEwen; D A Greene
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

2.  The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population.

Authors:  A J Boulton; G Knight; J Drury; J D Ward
Journal:  Diabetes Care       Date:  1985 Mar-Apr       Impact factor: 19.112

3.  A comparison of the microvascular lesions in diabetes mellitus with those in normal aging.

Authors:  R Vracko
Journal:  J Am Geriatr Soc       Date:  1982-03       Impact factor: 5.562

4.  Distal slowing of motor nerve conduction velocity in diabetic polyneuropathy.

Authors:  J Kimura; T Yamada; N P Stevland
Journal:  J Neurol Sci       Date:  1979-07       Impact factor: 3.181

5.  The pupillary light reflex in diabetes mellitus: evaluation of a newly developed infrared light reflection method.

Authors:  A de Vos; J T Marcus; J P Reulen; H F Peters; J J Heimans; E A van der Veen
Journal:  Diabetes Res       Date:  1989-04

6.  Electron microscopical studies of vessels in diabetic peripheral neuropathy.

Authors:  E Williams; W R Timperley; J D Ward; T Duckworth
Journal:  J Clin Pathol       Date:  1980-05       Impact factor: 3.411

7.  Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry.

Authors:  P J Dyck; W R Sherman; L M Hallcher; F J Service; P C O'Brien; L A Grina; P J Palumbo; C J Swanson
Journal:  Ann Neurol       Date:  1980-12       Impact factor: 10.422

8.  Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy.

Authors:  P J Dyck; A Lais; J L Karnes; P O'Brien; R Rizza
Journal:  Ann Neurol       Date:  1986-05       Impact factor: 10.422

9.  Pathogenesis of diabetic neuropathy.

Authors:  P C Johnson; S C Doll; D W Cromey
Journal:  Ann Neurol       Date:  1986-05       Impact factor: 10.422

10.  Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy.

Authors:  P J Dyck; J L Karnes; J Daube; P O'Brien; F J Service
Journal:  Brain       Date:  1985-12       Impact factor: 13.501

View more
  7 in total

1.  Neurophysiological tests in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients with subclinical and symptomatic neuropathy.

Authors:  D Ziegler; H Mühlen; F A Gries
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

2.  Treatment of diabetic polyneuropathy with the neurotrophic peptide ORG 2766.

Authors:  G D Valk; A C Kappelle; A M Tjon-A-Tsien; B Bravenboer; K Bakker; R P Michels; C M Groenhout; F W Bertelsmann
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

3.  Structure-function relationships within peripheral nerves in diabetic neuropathy: the hydration hypothesis.

Authors:  R P Eaton; C Qualls; J Bicknell; W L Sibbitt; M K King; R H Griffey
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

4.  Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus.

Authors:  A I Blakemore; A Cox; A M Gonzalez; J K Maskil; M E Hughes; R M Wilson; J D Ward; G W Duff
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

5.  Larger tonic pupil size in young children with autism spectrum disorder.

Authors:  Christa J Anderson; John Colombo
Journal:  Dev Psychobiol       Date:  2009-03       Impact factor: 3.038

6.  Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes model.

Authors:  Tie-Jun Sten Shi; Ming-Dong Zhang; Hugo Zeberg; Johanna Nilsson; Jacob Grünler; Su-Xing Liu; Qiong Xiang; Jonas Persson; Kaj J Fried; Sergiu Bogdan Catrina; Masahiko Watanabe; Peter Arhem; Kerstin Brismar; Tomas G M Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-24       Impact factor: 11.205

7.  Protective Effects of Green Tea Extract against Hepatic Tissue Injury in Streptozotocin-Induced Diabetic Rats.

Authors:  Ali Akbar Abolfathi; Daryoush Mohajeri; Ali Rezaie; Mehrdad Nazeri
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-27       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.